As of 2026-03-29, the Relative Valuation of Nova Mentis Life Science Corp (NOVA.CN) is (0.43) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 CAD, the upside of Nova Mentis Life Science Corp based on Relative Valuation is -1175.5%.
The range of the Relative Valuation is (0.55) - (0.31) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.2x - 12.2x | 12.2x |
| Forward P/E multiples | 6.8x - 6.8x | 6.8x |
| Fair Price | (0.55) - (0.31) | (0.43) |
| Upside | -1481.2% - -869.9% | -1175.5% |
| Date | P/E |